Explore All Access
Check if your research matches the topics covered in Cancer Nanotechnology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Nanotechnology : Impact Factor & More
eISSN: 1868-6966pISSN: 1868-6958
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancer Nanotechnology Key Metrics
CiteScore 
6.8
Eigenfactor
< 0.001
H-Index
32
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.39
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months37%
4 to 6 months45%
7 to 9 months16%
Above 9 months2%
Did you find this useful?
Topics Covered on Cancer Nanotechnology
Chitosan
Protein Corona
Hyperthermia
Computed tomography
Breast cancer
Electrochemiluminescence
Cancer Nanotechnology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 1590 | USD 1890 | GBP 1340 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Cancer Nanotechnology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Nanotechnology
Correction: Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage
- 1 Dec 2024
- Cancer Nanotechnology
Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
- 22 Nov 2024
- Cancer Nanotechnology
The potential of HSA-stabilized zinc oxide nanoparticles as radiosensitizers to enhance the cytotoxic effects and radiosensitivity of cervical cancer cells
- 20 Nov 2024
- Cancer Nanotechnology
Artemisinin-loaded mesoporous silica nanoparticles/electrospun poly(lactic-co-glycolic acid) composite nanofibers for enhanced anticancer efficiency in breast cancer cells
- 20 Nov 2024
- Cancer Nanotechnology
Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers
- 16 Nov 2024
- Cancer Nanotechnology
Near-infrared modulated photothermal/nanozymatic dual-modal strategy for combating cancer via molybdenum selenide nanourchins
- 4 Nov 2024
- Cancer Nanotechnology
Correction: Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage
- 1 Dec 2024
- Cancer Nanotechnology
Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
- 22 Nov 2024
- Cancer Nanotechnology
The potential of HSA-stabilized zinc oxide nanoparticles as radiosensitizers to enhance the cytotoxic effects and radiosensitivity of cervical cancer cells
- 20 Nov 2024
- Cancer Nanotechnology
Artemisinin-loaded mesoporous silica nanoparticles/electrospun poly(lactic-co-glycolic acid) composite nanofibers for enhanced anticancer efficiency in breast cancer cells
- 20 Nov 2024
- Cancer Nanotechnology
Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers
- 16 Nov 2024
- Cancer Nanotechnology
Near-infrared modulated photothermal/nanozymatic dual-modal strategy for combating cancer via molybdenum selenide nanourchins
- 4 Nov 2024
- Cancer Nanotechnology
Compare Similar Journals with Cancer Nanotechnology
Select Journals to Compare with Cancer Nanotechnology
Total journals - 9
You can select up to 3 Journals at a time
Scientific Reports
Publisher: NATURE PORTFOLIO
Journal of Materials Chemistry B
Publisher: Royal Society of Chemistry
ACS Biomaterials Science and Engineering
Publisher: AMER CHEMICAL SOC
ACS applied materials & interfaces
Publisher: AMER CHEMICAL SOC
Cancers
Publisher: MDPI
RSC Advances
Publisher: ROYAL SOC CHEMISTRY
Materials Science and Engineering C
Publisher: Elsevier
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
BioMed Research International
Publisher: HINDAWI LTD
0 Journals Selected to compare with
Cancer Nanotechnology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Nanotechnology
How long has Cancer Nanotechnology been actively publishing? 
Cancer Nanotechnology has been in operation since 2010 till date.
What is the publishing frequency of Cancer Nanotechnology?
Cancer Nanotechnology published with a Continuous publication frequency.
How many articles did Cancer Nanotechnology publish last year?
In 2023, Cancer Nanotechnology publsihed 85 articles.
What is the eISSN & pISSN for Cancer Nanotechnology?
For Cancer Nanotechnology, eISSN is 1868-6966 and pISSN is 1868-6958.
What is Citescore for Cancer Nanotechnology?
Citescore for Cancer Nanotechnology is 6.8.
What is the H Index for Cancer Nanotechnology ?
H Index for Cancer Nanotechnology is 32.
What is SNIP score for Cancer Nanotechnology?
SNIP score for Cancer Nanotechnology is 1.39.
What is the SJR for Cancer Nanotechnology?
SJR for Cancer Nanotechnology is Q1.
Who is the publisher of Cancer Nanotechnology?
BMC is the publisher of Cancer Nanotechnology.
